The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ABBVIE INC COM 00287Y109 3,066 35,000 SH   SOLE   35,000 0 0
ADAMAS PHARMACEUTICALS INC COM 00548A106 412 100,000 SH   SOLE   100,000 0 0
AMARIN CORP PLC SPONS ADR NEW 023111206 421 100,000 SH Call SOLE   100,000 0 0
ANTARES PHARMA INC COM 036642106 1,350 500,000 SH   SOLE   500,000 0 0
CARDINAL HEALTH INC COM 14149Y108 1,174 25,000 SH   SOLE   25,000 0 0
CLOVIS ONCOLOGY INC COM 189464100 1,458 250,000 SH   SOLE   250,000 0 0
GILEAD SCIENCES INC COM 375558103 3,160 50,000 SH   SOLE   50,000 0 0
GLAXOSMITHKLINE PLC SPONSORED ADR 37733W105 3,764 100,000 SH   SOLE   100,000 0 0
GREENLANE HLDGS INC CL A 395330103 560 250,000 SH   SOLE   250,000 0 0
JAZZ PHARMACEUTICALS PLC SHS USD G50871105 3,565 25,000 SH   SOLE   25,000 0 0
MCKESSON CORP COM 58155Q103 1,489 10,000 SH   SOLE   10,000 0 0
MODERNA INC COM 60770K107 708 10,000 SH Put SOLE   10,000 0 0
NOVAVAX INC COM NEW 670002401 542 5,000 SH Put SOLE   5,000 0 0
PROSHARES TR ULTRAPRO SHORT S 74347B268 2,175 250,000 SH   SOLE   250,000 0 0
PROSHARES TR ULTRAPRO SHORT S 74347B268 870 100,000 SH Call SOLE   100,000 0 0
PROSHARES TR II VIX SH TRM FUTRS 74347W171 510 25,000 SH Call SOLE   25,000 0 0
TYME TECHNOLOGIES INC COM 90238J103 2,132 2,175,000 SH   SOLE   2,175,000 0 0
VYNE THERAPEUTICS INC COM NEW 92941V100 2,988 1,800,000 SH   SOLE   1,800,000 0 0